Correlation Between Actinium Pharmaceuticals and Mink Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Actinium Pharmaceuticals and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Actinium Pharmaceuticals and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Actinium Pharmaceuticals and Mink Therapeutics, you can compare the effects of market volatilities on Actinium Pharmaceuticals and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Actinium Pharmaceuticals with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Actinium Pharmaceuticals and Mink Therapeutics.

Diversification Opportunities for Actinium Pharmaceuticals and Mink Therapeutics

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Actinium and Mink is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Actinium Pharmaceuticals and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and Actinium Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Actinium Pharmaceuticals are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of Actinium Pharmaceuticals i.e., Actinium Pharmaceuticals and Mink Therapeutics go up and down completely randomly.

Pair Corralation between Actinium Pharmaceuticals and Mink Therapeutics

Given the investment horizon of 90 days Actinium Pharmaceuticals is expected to under-perform the Mink Therapeutics. In addition to that, Actinium Pharmaceuticals is 1.07 times more volatile than Mink Therapeutics. It trades about -0.05 of its total potential returns per unit of risk. Mink Therapeutics is currently generating about -0.02 per unit of volatility. If you would invest  182.00  in Mink Therapeutics on August 30, 2024 and sell it today you would lose (110.00) from holding Mink Therapeutics or give up 60.44% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Actinium Pharmaceuticals  vs.  Mink Therapeutics

 Performance 
       Timeline  
Actinium Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Actinium Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Mink Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mink Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's forward-looking signals remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Actinium Pharmaceuticals and Mink Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Actinium Pharmaceuticals and Mink Therapeutics

The main advantage of trading using opposite Actinium Pharmaceuticals and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Actinium Pharmaceuticals position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.
The idea behind Actinium Pharmaceuticals and Mink Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
CEOs Directory
Screen CEOs from public companies around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Volatility Analysis
Get historical volatility and risk analysis based on latest market data